Item 8.01 Other Events.
CNS Pharmaceuticals, Inc. (the "Company") held its scheduled Annual Meeting of
Stockholders at Wells Fargo Center, 13th Floor - Twin Peak Boardroom, 299 S Main
St, Salt Lake City, UT 84111, on Wednesday, July 27, 2022, at 9:00 a.m. (MT).
After counting the number of shares present in person and by proxy, Company
Secretary Christopher Downs determined that a quorum for the transaction of
business was not present. Under Section 2.08 of the Company's Bylaws and
pursuant to Nevada Revised Statutes 78.370(7), the Company Secretary proposed a
vote of shares present to adjourn the meeting until August 3, 2022, at 9:00 a.m.
in the same location. The proposal was passed with proxy shares being voted by
their representatives pursuant to discretionary voting power granted under the
proxy. Upon recommencement of the meeting on August 3, 2022, and after counting
the number of shares present in person and by proxy, Company Secretary
Christopher Downs determined that a quorum for the transaction of business was
not present. The Company Secretary proposed a vote of shares present to adjourn
the meeting until August 16, 2022, at 9:00 a.m. in the same location. The
proposal was passed with proxy shares being voted by their representatives
pursuant to discretionary voting power granted under the proxy. Upon
recommencement of the meeting on August 16, 2022, and after counting the number
of shares present in person and by proxy, Company Secretary Christopher Downs
determined that a quorum for the transaction of business was not present. The
Company Secretary proposed a vote of shares present to adjourn the meeting until
August 25, 2022, at 9:00 a.m. in the same location. The proposal was passed with
proxy shares being voted by their representatives pursuant to discretionary
voting power granted under the proxy.
Therefore, the Annual Meeting of the Stockholders has been adjourned until
August 25, 2022, to be held at Wells Fargo Center, 13th Floor - Twin Peak
Boardroom, 299 S Main St, Salt Lake City, UT 84111, at 9:00 a.m. (MT). All
business to be transacted at the Annual Meeting remains the same.
2
© Edgar Online, source Glimpses
CNS PHARMACEUTICALS, INC. 
